MaxWell Biosystems

MaxWell Biosystems Provides Next-Generation High-Content Electrophysiology Platforms to Facilitate Detailed Research on In Vitro Cells. MaxOne and MaxTwo are Microelectrode Array Systems, Ideal for Phenotypic Human iPSC-Derived Neuronal Disease Models and Screening Pharmacological Compounds. The High Electrode Density and High Signal-to-Noise Ratio Ensure the Capture and Analysis of Each Individual Cell, Providing Insights into the Functionality and Maturity of Neuronal Networks.